Yi Ping Li
Chief Executive Officer chez JW (CAYMAN) THERAPEUTICS CO. LTD
Fortune : 5 M $ au 31/03/2024
Profil
Yi Ping Li is the Chairman & Chief Executive Officer of JW (Cayman) Therapeutics Co. Ltd.
which he founded in 2017.
He is also the founder of JW Biotechnology (Shanghai) Co. Ltd., JW Therapeutics (Shanghai) Co., Ltd.
and holds the title of Director at GenScript Corp.
Dr. Li's former positions include Medical Director at Merck Serono SA from 1996 to 2006, Director at China Kanghui Holdings from 2009 to 2010, Partner at Kleiner Perkins Caufield & Byers LLC, Principal at KPCB (China) Advisory Co. Ltd., and General Manager at Amgen Biotechnology Consulting Shanghai Co., Ltd.
from 2012 to 2015.
Dr. Li received a graduate degree from The University of Montana in 1991 and a doctorate degree from Shanghai Jiao Tong University in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/06/2023 | 22 042 212 ( 5,34% ) | 5 M $ | 31/03/2024 |
Postes actifs de Yi Ping Li
| Sociétés | Poste | Début |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Chief Executive Officer | 14/11/2017 |
GenScript Corp.
 GenScript Corp. BiotechnologyHealth Technology GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ. | Director/Board Member | 27/07/2010 |
| JW Biotechnology (Shanghai) Co. Ltd. | Founder | - |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Anciens postes connus de Yi Ping Li
| Sociétés | Poste | Fin |
|---|---|---|
| Amgen Biotechnology Consulting Shanghai Co., Ltd. | Chief Executive Officer | 01/07/2015 |
China Kanghui Holdings
 China Kanghui Holdings Medical SpecialtiesHealth Technology China Kanghui Holdings operates as a holding company that develops, manufactures and markets orthopedic implants. The company was founded by Yi Kang Jiang on April 19, 2006 and is headquartered in Changzhou, China. | Director/Board Member | 08/11/2010 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 30/08/2006 |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Corporate Officer/Principal | - |
KPCB (China) Advisory Co. Ltd.
 KPCB (China) Advisory Co. Ltd. Investment ManagersFinance KPCB (China) Advisory Co. Ltd.(KPCB China Advisory) is a Private Equity/Venture Capital firm, a subsidiary of Kleiner Perkins Caufield & Byers LLC founded in 2006 by Tina Ju. The firm is headquartered in Shanghai. | Corporate Officer/Principal | - |
Formation de Yi Ping Li
| The University of Montana | Graduate Degree |
| Shanghai Jiao Tong University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
| Entreprise privées | 8 |
|---|---|
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Finance |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
KPCB (China) Advisory Co. Ltd.
KPCB (China) Advisory Co. Ltd. Investment ManagersFinance KPCB (China) Advisory Co. Ltd.(KPCB China Advisory) is a Private Equity/Venture Capital firm, a subsidiary of Kleiner Perkins Caufield & Byers LLC founded in 2006 by Tina Ju. The firm is headquartered in Shanghai. | Finance |
GenScript Corp.
GenScript Corp. BiotechnologyHealth Technology GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ. | Health Technology |
China Kanghui Holdings
China Kanghui Holdings Medical SpecialtiesHealth Technology China Kanghui Holdings operates as a holding company that develops, manufactures and markets orthopedic implants. The company was founded by Yi Kang Jiang on April 19, 2006 and is headquartered in Changzhou, China. | Health Technology |
| JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
| Amgen Biotechnology Consulting Shanghai Co., Ltd. |
